| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0769-2625(87)80030-2 |
| P698 | PubMed publication ID | 2964247 |
| P2093 | author name string | R M Locksley | |
| B J Holaday | |||
| F P Heinzel | |||
| M D Sadick | |||
| K D Gardner | |||
| P2860 | cites work | A prospective study of visceral leishmaniasis in an endemic area of Brazil. | Q50575676 |
| P433 | issue | 5 | |
| P921 | main subject | cutaneous leishmaniasis | Q2590966 |
| P304 | page(s) | 744-749 | |
| P577 | publication date | 1987-09-01 | |
| P1433 | published in | Annales de l'Institut Pasteur. Immunologie | Q27709020 |
| P1476 | title | Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets | |
| P478 | volume | 138 |
| Q34519899 | A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy |
| Q36711264 | A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing |
| Q77143665 | A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis |
| Q39392471 | A strong antigen-specific T-cell response is associated with age and genetically dependent resistance to avian enteric salmonellosis. |
| Q38342306 | Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid |
| Q47586079 | Acyloxyacyl hydrolase modulates pelvic pain severity |
| Q54379569 | Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3. |
| Q41827630 | Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences |
| Q35738105 | Amblyomma maculatum Feeding Augments Rickettsia parkeri Infection in a Rhesus Macaque Model: A Pilot Study |
| Q61690576 | Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection |
| Q36960086 | Antibody response to Salmonella: its induction and role in protection against avian enteric salmonellosis |
| Q36945113 | Aspergillus antigen-induced eosinophil differentiation in a murine model |
| Q50937237 | CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis. |
| Q33725704 | CD8+ T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis |
| Q39589605 | Caseous necrosis in cutaneous leishmaniasis |
| Q39860086 | Cell-mediated responses of immunized vervet monkeys to defined Leishmania T-cell epitopes. |
| Q35548417 | Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model |
| Q34132796 | Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections |
| Q36010722 | Comparative immune study on cutaneous leishmaniasis patients with single and multiple sores |
| Q81641767 | Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization |
| Q43565851 | Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans |
| Q36396770 | Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice |
| Q37526325 | Cyclosporine-induced autoimmunity and immune hyperreactivity |
| Q54107806 | Cytokines in parasitic diseases: the example of cutaneous leishmaniasis. |
| Q52726750 | Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development. |
| Q28077110 | Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery |
| Q60627937 | Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice |
| Q34259867 | Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells |
| Q45184932 | Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania |
| Q56880374 | Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major |
| Q36311026 | Efficacy of Microwave and Infrared Radiation in the Treatment of the Skin Lesions Caused by Leishmania major in an Animal Model |
| Q34853387 | Enhanced murine antigen-specific gamma interferon and immunoglobulin G2a responses by using mycobacterial ESAT-6 sequences in DNA vaccines |
| Q37728996 | Environmental enrichment alters splenic immune cell composition and enhances secondary influenza vaccine responses in mice |
| Q37005098 | Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major |
| Q54648290 | Expansion of CD4 T cells expressing a highly restricted TCR structure specific for a single parasite epitope correlates with high pathology in murine schistosomiasis. |
| Q38635548 | Experiences with vaccines against cutaneous leishmaniasis: of men and mice |
| Q34341389 | Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand |
| Q40541534 | Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs. |
| Q36691050 | Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis |
| Q33672040 | Histologic diagnosis of cutaneous leishmaniasis |
| Q77222175 | Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum |
| Q45066039 | Immune response induced by New World Leishmania species in C57BL/6 mice. |
| Q69208562 | Immunity to experimental infection with Leishmania major: generation of protective L3T4+ T cell clones recognizing antigen(s) associated with live parasites |
| Q34440997 | Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria |
| Q35254548 | Immunobiology of experimental leishmaniasis |
| Q72600523 | Immunology of leishmaniasis |
| Q36778997 | Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection |
| Q69737478 | In vitro and in vivo effects of interleukin 2 on the protozoan parasite leishmania |
| Q36949600 | Induction and regulation of pathogenic Th17 cell responses in schistosomiasis |
| Q35895182 | Influence of asthma epidemiology on the risk for other diseases |
| Q58861573 | Insulin-Like Growth Factor-I as an Effector Element of the Cytokine IL-4 in the Development of a Infection |
| Q45544872 | L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1). |
| Q35783219 | Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. |
| Q36640255 | Leishmaniases of the New World: current concepts and implications for future research |
| Q56880375 | Leishmaniasis host response loci (lmr1–3) modify disease severity through a Th1/Th2-independent pathway |
| Q41828552 | Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis |
| Q36205512 | Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates. |
| Q87627592 | Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice |
| Q33939868 | New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice |
| Q38719216 | Optimization of the Timing of Induction for the Assessment of Nitric Oxide Production in Leishmania major Infected Macrophage Cells |
| Q48270562 | Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice |
| Q38540870 | Permissive and protective roles for neutrophils in leishmaniasis. |
| Q41593015 | Plasmodium attenuation: connecting the dots between early immune responses and malaria disease severity |
| Q39511812 | Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro. |
| Q35915428 | Reactive oxygen species and nitric oxide in cutaneous leishmaniasis. |
| Q35913436 | Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand |
| Q33711756 | Regulation of Gastric Carcinogenesis by Inflammatory Cytokines. |
| Q36377170 | Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9 |
| Q41013010 | Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication |
| Q36230339 | Selection of a human T helper type 1-like T cell subset by mycobacteria |
| Q47889363 | Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major |
| Q36765617 | Sex impacts Th1 cells, Tregs, and DCs in both intestinal and systemic immunity in a mouse strain and location-dependent manner |
| Q72508174 | T helper subset involvement in two high antibody responder lines of mice (Biozzi mice): HI (susceptible) and HII (resistant) to collagen-induced arthritis |
| Q53912448 | TRANCE-RANK Costimulation is Required for IL-12 Production and the Initiation of a Th1-Type Response toLeishmania majorInfection in CD40L-Deficient Mice |
| Q55339940 | The Cryptococcus neoformans Titan cell is an inducible and regulated morphotype underlying pathogenesis. |
| Q37174541 | The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani |
| Q38635543 | The Wellcome Trust lecture. Problems specific to parasite vaccines |
| Q35036907 | The absence of CCR7 results in dysregulated monocyte migration and immunosuppression facilitating chronic cutaneous leishmaniasis |
| Q36401381 | The central role of CD4(+) T cells in the antitumor immune response |
| Q92209373 | The evolving role of T-bet in resistance to infection |
| Q33799813 | The host response to Leishmania infection. |
| Q35535838 | The immune system in health and disease |
| Q54355844 | The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment. |
| Q34039477 | The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein |
| Q34944681 | The site of Leishmania major infection determines disease severity and immune responses |
| Q43434397 | Time dependent expression of cytokines in Mycobacterium bovis infected cattle lymph nodes. |
| Q53685684 | Trypanosomatid Infections: How Do Parasites and Their Excreted-Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages? |
| Q34105379 | Type 1/Type 2 immunity in infectious diseases |
| Q22241439 | Vaccination Strategies for Alzheimer???s Disease |
Search more.